Dutch Healthtech Firm Secures Fresh Capital to Improve Hospital Surgical Workflows
Amsterdam, Friday, 13 November 2026.
Incision secured €4 million to expand its operating room platform into the US, tackling critical hospital staff shortages with software that cuts surgical turnover times by 15%.
Capital Infusion for Surgical Workflow Software
Operating in the healthtech sector [2], Amsterdam-based surgical software developer Incision has raised €4 million in fresh equity financing announced on November 13, 2026 [1][2]. The capital injection was led entirely by HERAN Partners via its specialized HERAN HealthTech Fund II, representing the third portfolio investment deployed by this vehicle [1][3][4]. Under the terms of the transaction, Mercedes Tuin, a partner at HERAN Partners, has been appointed to Incision’s Supervisory Board [1][3]. According to leadership, the funding is earmarked to accelerate the company’s operational scaling within the United States hospital market, execute partnership roll-outs with global medical technology providers, and advance ongoing platform engineering [1][3][4].
Consolidating Clinical Knowledge to Tackle Staff Shortages
The technology addresses operational friction in acute medical settings by digitizing and standardizing workflow preparation [1][4]. Originally founded in Amsterdam, Netherlands, in 2014 by Prof. Dr. Theo Wiggers [1][2][4] [alert! ‘Startup.eu FAQ conflictingly notes founded date as 2026-11-13, whereas Dealroom and narrative text confirm founded in 2014’], Incision builds digital tools designed for operating room and sterile processing department personnel [1][2]. In standard clinical environments, critical setup details are fragmented across legacy paper records, individual electronic preference cards, disparate work instructions, and unwritten staff routines [1][4]. Incision’s suite unites this knowledge into centralized, accessible interfaces [1][4].
Mechanics and Measured Clinical Outcomes
The company’s product line includes Incision Assist for operating room setup, MySPD for sterile processing training and competency tracking, and Incision Academy for accredited surgical education [1][2]. Incision Assist delivers procedure-, role-, and surgeon-specific guidance detailing required instruments, materials, and operating theater configurations, reinforced by photos, instructional videos, and three-dimensional visual layouts [3][4]. The innovation serves to mitigate avoidable procedural delays, eliminate intraoperative disruptions, and decrease variation in tray assembly, which is especially critical as healthcare facilities manage high staff turnover and growing reliance on temporary or newly onboarded workers [4]. Clinical sites implementing the Assist platform have reported measurable operational efficiencies, including an operating room turnover time improvement of 15% alongside a 14% drop in intraoperative door movements [1][3][4].
Strategic Expansion into the US Healthcare Landscape
Led by Chief Executive Officer Ritsaart van Montfrans, Incision’s solutions are currently deployed across approximately 300 hospitals throughout more than 20 countries [1][4]. The healthtech scale-up initiated its entry into the United States market in 2022, securing engagements with academic medical centers, multi-facility hospital systems, and medical technology enterprises that integrate its software into medical devices [1][4]. Building on prior US market developments, including a 2025 collaboration involving Tanner Health and Healthliant Ventures [4], this €4 million round supports sustained expansion into a complex US hospital network striving to optimize operating room throughput and curb procedural supply costs [1][4].